RAM
APGE icon

Readystate Asset Management’s Apogee Therapeutics APGE Stock Holding History

Readystate Asset Management’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,400
Closed -$1.06M – 602
2024
Q4 		$1.06M Buy
+23,400
New +$1.19M 0.03% 388

Other funds holding APGE

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Readystate Asset Management's APGE Position: Q1 2025 in Review

Readystate Asset Management sold out of Apogee Therapeutics (APGE) in Q1 2025, closing a stake of 23,400 shares — an estimated $1.06M sold.

Readystate Asset Management first reported a position in APGE in Q4 2024 and held it in 1 quarter. The position peaked at $1.06M in Q4 2024. 168 funds tracked by Wall St. Rank hold APGE as of Q1 2025.

  • Readystate Asset Management reported no remaining Apogee Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Readystate Asset Management sold 23,400 Apogee Therapeutics shares in Q1 2025, an estimated $1.06M.
  • Readystate Asset Management first reported a position in Apogee Therapeutics in Q4 2024 and held it in 1 quarter.
  • Readystate Asset Management's Apogee Therapeutics position peaked at $1.06M in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.